MPH Health Care Future Growth
Future criteria checks 2/6
MPH Health Care is forecast to grow earnings and revenue by 8.4% and 6% per annum respectively while EPS is expected to decline by 107.3% per annum.
Key information
8.4%
Earnings growth rate
-107.3%
EPS growth rate
Pharmaceuticals earnings growth | 19.4% |
Revenue growth rate | 6.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 12 Jun 2024 |
Recent future growth updates
Recent updates
If You Had Bought MPH Health Care's (ETR:93M) Shares A Year Ago You Would Be Down 28%
Aug 10What Type Of Returns Would MPH Health Care's(ETR:93M) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Aug 10We Think MPH Health Care's (ETR:93M) Statutory Profit Might Understate Its Earnings Potential
Jul 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 39 | 35 | 12 | 11 | 1 |
12/31/2024 | 37 | 33 | 12 | 10 | 1 |
12/31/2023 | 34 | 30 | -2 | -2 | N/A |
9/30/2023 | 33 | 40 | -1 | -1 | N/A |
6/30/2023 | 31 | 50 | -1 | -1 | N/A |
3/31/2023 | 31 | 39 | 0 | 0 | N/A |
12/31/2022 | 31 | 29 | 0 | 0 | N/A |
9/30/2022 | 10 | -20 | -1 | -1 | N/A |
6/30/2022 | -11 | -68 | -1 | -1 | N/A |
3/31/2022 | 1 | -39 | -1 | -1 | N/A |
12/31/2021 | 14 | -9 | -1 | -1 | N/A |
9/30/2021 | 18 | -12 | -1 | -1 | N/A |
6/30/2021 | 22 | -14 | -1 | -1 | N/A |
3/31/2021 | 13 | -42 | -2 | -2 | N/A |
12/31/2020 | 3 | -70 | -3 | -3 | N/A |
9/30/2020 | 20 | -37 | -2 | -2 | N/A |
6/30/2020 | 38 | -3 | -1 | -1 | N/A |
3/31/2020 | 39 | 4 | -1 | -1 | N/A |
12/31/2019 | 41 | 11 | -1 | -1 | N/A |
9/30/2019 | 19 | -13 | 0 | 0 | N/A |
6/30/2019 | -3 | -37 | 1 | 1 | N/A |
3/31/2019 | 21 | 0 | 3 | 3 | N/A |
12/31/2018 | 45 | 37 | 5 | 5 | N/A |
9/30/2018 | 64 | 63 | 1 | 1 | N/A |
6/30/2018 | 84 | 90 | -2 | -2 | N/A |
3/31/2018 | 59 | 61 | -1 | -1 | N/A |
12/31/2017 | 34 | 32 | 1 | 1 | N/A |
9/30/2017 | 22 | 45 | N/A | 0 | N/A |
6/30/2017 | 10 | 58 | N/A | 0 | N/A |
3/31/2017 | 10 | 69 | N/A | -3 | N/A |
12/31/2016 | 9 | 80 | N/A | -5 | N/A |
9/30/2016 | 83 | 90 | N/A | -2 | N/A |
6/30/2016 | 156 | 100 | N/A | 1 | N/A |
3/31/2016 | 210 | 91 | N/A | 1 | N/A |
12/31/2015 | 263 | 83 | N/A | 0 | N/A |
9/30/2015 | 239 | 43 | N/A | 1 | N/A |
6/30/2015 | 214 | 3 | N/A | 3 | N/A |
3/31/2015 | 217 | 4 | N/A | 1 | N/A |
12/31/2014 | 219 | 5 | N/A | 0 | N/A |
9/30/2014 | 226 | 6 | N/A | -3 | N/A |
6/30/2014 | 232 | 7 | N/A | -6 | N/A |
3/31/2014 | 229 | 7 | N/A | -5 | N/A |
12/31/2013 | 227 | 6 | N/A | -4 | N/A |
9/30/2013 | 223 | 9 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 93M1's forecast earnings growth (8.4% per year) is above the savings rate (0.8%).
Earnings vs Market: 93M1's earnings (8.4% per year) are forecast to grow slower than the German market (20% per year).
High Growth Earnings: 93M1's earnings are forecast to grow, but not significantly.
Revenue vs Market: 93M1's revenue (6% per year) is forecast to grow faster than the German market (5.3% per year).
High Growth Revenue: 93M1's revenue (6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 93M1's Return on Equity is forecast to be high in 3 years time